Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD

J Behav Addict. 2018 Mar 1;7(1):192-203. doi: 10.1556/2006.6.2017.081. Epub 2018 Jan 10.

Abstract

Background Addictive-like behaviors (e.g., hoarding and shopping) may be the result of the cumulative effects of dopaminergic and other neurotransmitter genetic variants as well as elevated stress levels. We, therefore, propose that dopamine homeostasis may be the preferred goal in combating such challenging and unwanted behaviors, when simple dopaminergic activation through potent agonists may not provide any resolution. Case presentation C.J. is a 38-year-old, single, female, living with her mother. She has a history of substance use disorder as well as attention deficit hyperactivity disorder, inattentive type. She had been stable on buprenorphine/naloxone combination and amphetamine, dextroamphetamine mixed salts for many years when unexpectedly she lost her job for oversleeping and not calling into work. KB200z (a pro-dopamine compound) was added to her regimen for complaints of low drive and motivation. After taking this nutraceutical for 4 weeks, she noticed a marked improvement in her mental status and many behaviors. She noted that her shopping and hoarding addictions had appreciably decreased. Furthermore, her lifelong history of terrifying lucid dreams was eliminated. Finally, she felt more in control; her locus of control shifted from external to more internal. Discussion The hypothesis is that C.J.'s reported, behavioral, and psychological benefits resulted from the pro-dopamine-regulating effect of KB220Z across the brain reward system. Conclusions This effect, we surmise, could be the result of a new dopamine balance, across C.J.'s brain reward system. Dopamine homeostasis is an effect of KB220Z seen in both animal and human placebo-controlled fMRI experiments.

Keywords: attention-deficit/hyperactivity disorder (ADHD); hoarding and shopping behaviors; pro-dopamine regulation (KB220Z); reward deficiency syndrome (RDS).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Attention Deficit Disorder with Hyperactivity* / complications
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Attention Deficit Disorder with Hyperactivity* / psychology
  • Catecholamines / therapeutic use
  • Dopamine Agents* / therapeutic use
  • Female
  • Hoarding Disorder* / complications
  • Hoarding Disorder* / drug therapy
  • Humans
  • Monoamine Oxidase / therapeutic use
  • Neprilysin / therapeutic use
  • Psychotropic Drugs* / therapeutic use
  • Substance-Related Disorders* / complications
  • Substance-Related Disorders* / drug therapy
  • Substance-Related Disorders* / psychology

Substances

  • Catecholamines
  • Dopamine Agents
  • KB220Z
  • Monoamine Oxidase
  • Neprilysin
  • Psychotropic Drugs

Grants and funding

Funding sources: Drs. KB and ERB are co-recipients of a grant from The Life Extension Foundation, Ft. Lauderdale, FL, USA to Path Foundation, NY, USA. Dr. RDB is supported by the National Institutes of Health grants 1R01NS073884 and 1R21MH073624.